🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/04/2014 | 55,83 | 56,30 | 55,36 | 55,88 | -0,27% | 1,67% | 14.211.299 |
| 29/04/2014 | 54,87 | 56,16 | 54,65 | 56,03 | +3,60% | 2,77% | 14.317.252 |
| 28/04/2014 | 54,97 | 55,20 | 53,89 | 54,08 | -0,98% | 2,38% | 17.807.826 |
| 25/04/2014 | 54,90 | 55,04 | 54,41 | 54,62 | -0,50% | 1,15% | 6.526.630 |
| 24/04/2014 | 54,69 | 55,17 | 54,25 | 54,90 | +0,05% | 1,69% | 7.037.110 |
| 23/04/2014 | 55,11 | 55,12 | 54,47 | 54,87 | -0,47% | 1,19% | 8.107.433 |
| 22/04/2014 | 54,48 | 55,65 | 54,41 | 55,12 | +0,91% | 2,28% | 14.642.866 |
| 21/04/2014 | 53,97 | 54,68 | 53,82 | 54,63 | +1,38% | 1,59% | 6.530.088 |
| 17/04/2014 | 53,86 | 54,39 | 53,69 | 53,88 | +0,37% | 1,29% | 11.804.358 |
| 16/04/2014 | 53,86 | 54,34 | 53,37 | 53,68 | +0,37% | 1,81% | 10.098.004 |
| 15/04/2014 | 53,23 | 53,73 | 52,59 | 53,48 | +0,86% | 2,15% | 11.677.759 |
| 14/04/2014 | 53,65 | 54,13 | 52,43 | 53,02 | -0,63% | 3,17% | 11.304.776 |
| 11/04/2014 | 53,01 | 54,01 | 52,77 | 53,36 | +0,13% | 2,34% | 14.286.022 |
| 10/04/2014 | 55,24 | 55,48 | 53,23 | 53,29 | -2,19% | 4,08% | 18.883.388 |
| 09/04/2014 | 52,69 | 54,53 | 52,67 | 54,48 | +3,74% | 3,53% | 16.881.708 |
| 08/04/2014 | 52,75 | 53,06 | 52,19 | 52,52 | -0,27% | 1,65% | 11.283.606 |
| 07/04/2014 | 52,83 | 53,59 | 52,51 | 52,66 | -1,66% | 2,04% | 11.974.762 |
| 04/04/2014 | 54,02 | 54,12 | 53,52 | 53,55 | -0,16% | 1,11% | 10.912.614 |
| 03/04/2014 | 53,94 | 54,15 | 53,39 | 53,64 | -0,44% | 1,42% | 8.712.129 |
| 02/04/2014 | 53,89 | 53,97 | 53,48 | 53,87 | +0,16% | 0,90% | 7.398.880 |
| 01/04/2014 | 54,06 | 54,24 | 53,44 | 53,79 | -0,70% | 1,46% | 8.085.739 |
| 31/03/2014 | 53,52 | 54,24 | 53,47 | 54,17 | +1,41% | 1,43% | 14.861.898 |
| 28/03/2014 | 53,64 | 54,35 | 53,22 | 53,42 | +0,45% | 2,12% | 9.390.394 |
| 27/03/2014 | 53,33 | 53,54 | 52,80 | 53,18 | -0,52% | 1,40% | 11.657.742 |
| 26/03/2014 | 52,89 | 53,87 | 52,85 | 53,45 | +1,50% | 1,93% | 13.701.133 |
| 25/03/2014 | 51,41 | 52,94 | 51,35 | 52,66 | +2,62% | 3,10% | 14.793.254 |
| 24/03/2014 | 52,35 | 52,35 | 51,12 | 51,32 | -1,61% | 2,35% | 16.244.838 |
| 21/03/2014 | 53,91 | 54,01 | 52,12 | 52,16 | -1,67% | 3,50% | 24.549.295 |
| 20/03/2014 | 53,27 | 53,32 | 52,78 | 53,04 | -0,71% | 1,02% | 8.866.918 |
| 19/03/2014 | 54,08 | 54,30 | 53,09 | 53,43 | -0,66% | 2,24% | 10.530.723 |